Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
p16 INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16 INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray study.
Han CP, Lee MY, Tyan YS, Kok LF, Yao CC, Wang PH, Hsu JD, Tseng SW. Han CP, et al. Among authors: kok lf. Virchows Arch. 2009 Oct;455(4):353-61. doi: 10.1007/s00428-009-0826-7. Epub 2009 Sep 9. Virchows Arch. 2009. PMID: 19763614
Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study.
Koo CL, Kok LF, Lee MY, Wu TS, Cheng YW, Hsu JD, Ruan A, Chao KC, Han CP. Koo CL, et al. Among authors: kok lf. J Transl Med. 2009 Apr 14;7:25. doi: 10.1186/1479-5876-7-25. J Transl Med. 2009. PMID: 19366452 Free PMC article.
Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study.
Kok LF, Lee MY, Tyan YS, Wu TS, Cheng YW, Kung MF, Wang PH, Han CP. Kok LF, et al. Arch Gynecol Obstet. 2010 Feb;281(2):293-300. doi: 10.1007/s00404-009-1094-0. Epub 2009 May 6. Arch Gynecol Obstet. 2010. PMID: 19418062
Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
Liao CL, Lee MY, Tyan YS, Kok LF, Wu TS, Koo CL, Wang PH, Chao KC, Han CP. Liao CL, et al. Among authors: kok lf. J Transl Med. 2009 May 28;7:37. doi: 10.1186/1479-5876-7-37. J Transl Med. 2009. PMID: 19476621 Free PMC article.
A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Han CP, Lee MY, Kok LF, Wu TS, Cheng YW, Wang PH, Yue CH, Tyan YS. Han CP, et al. Among authors: kok lf. Arch Gynecol Obstet. 2010 May;281(5):845-50. doi: 10.1007/s00404-009-1151-8. Epub 2009 Jul 15. Arch Gynecol Obstet. 2010. PMID: 19847454
23 results